TwinStrand Biosciences, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-27. The offering totals $4.0M, of which $1.2M was reported sold. Industry: Biotechnology.
Showing 25 of 31 people.
| Name | Role | Location |
|---|---|---|
| Christopher Benoit | Director | Lowell, MA |
| Lawrence Loeb | Director | Seattle, WA |
| Christopher Benoit | Executive Officer | Lowell, MA |
| Lawrence Loeb | Promoter | Seattle, WA |
| Jesse Salk | Director | SEATTLE, WA |
| Jesse Salk | Executive Officer | SEATTLE, WA |
| Jesse Salk | Promoter | SEATTLE, WA |
| Chad Waite | Director | SEATTLE, WA |
| Chad Waite | Executive Officer | SEATTLE, WA |
| Michael Pellini | Director | MENLO PARK, CA |
| Mike Pellini | Director | Solana Beach, CA |
| Ronnie Andrews | Executive Officer | Chicago, IL |
| Soma Somasegar | Director | Portland, ME |
| Jason Myers | Director | Santa Cruz, CA |
| Michael Schmitt | Director | Cincinnati, OH |
| Michael Schmitt | Promoter | Cincinnati, OH |
| KAREN DABBS | Executive Officer | SEATTLE, WA |
| DAVID CANNER | Director | SEATTLE, WA |
| Kellie Bickel | Executive Officer | Seattle, WA |
| Steve Dow | Director | Seattle, WA |
| Elena Cant | Executive Officer | Seattle, WA |
| Michele Fernandes | Executive Officer | Seattle, WA |
| Terry Myerson | Director | Seattle, WA |
| Chad Waite, Jr. | Director | Seattle, WA |
| Chad Waite, Jr. | Executive Officer | Seattle, WA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2023-06-30 | D | $25.7M | $10.3M |
| 2021-05-12 | D | $50.0M | $50.0M |
| 2019-12-30 | D | $16.3M | $16.3M |
| 2017-09-13 | D | $5.5M | $5.3M |
| 2016-06-24 | D | $2.3M | $1.9M |